Israel Englander’s Cano Health, Inc. CANO Stock Holding History

Israel Englander’s Portfolio CANO Stock Details CANO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-300	Closed	-$380K	–	7571
2021 Q3	$380K	Buy	+300	New	+$364K	﹤0.01%	5612

Other funds holding CANO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

OCAM

Owl Creek Asset Management New York $1.21B AUM 169.99% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

CCM

Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hudson Bay Capital Management Stamford, Connecticut $36.8B AUM 42.13% 1-Year Est. Return

Israel Englander's CANO Position: Q3 2023 in Review

Israel Englander sold out of Cano Health, Inc. (CANO) in Q3 2023, closing a stake of 2,168 shares — an estimated $301K sold.

Israel Englander first reported a position in CANO in Q3 2020 and held it in 12 quarters. The position peaked at $65.6M in Q3 2021. 134 funds tracked by Wall St. Rank hold CANO as of Q3 2023.

Israel Englander reported no remaining Cano Health, Inc. position as of Q3 2023 after selling out during the quarter.
Israel Englander sold 2,168 Cano Health, Inc. shares in Q3 2023, an estimated $301K.
Israel Englander first reported a position in Cano Health, Inc. in Q3 2020 and held it in 12 quarters.
Israel Englander's Cano Health, Inc. position peaked at $65.6M in Q3 2021.
134 funds tracked by Wall St. Rank held Cano Health, Inc. as of Q3 2023.

Based on Millennium Management's 13F filing for Q3 2023, filed 14 Nov 2023.